Programmes in development and commercialisation.
A portfolio of medicines, medical nutrition and medical foods being advanced for rare and inherited metabolic disorders — spanning discovery, formulation, clinical evaluation, regulatory review and commercialised products.
Information on this page describes products and programmes under development or commercialised by Meta Healthcare. Statements about development status and regulatory progress are factual and do not constitute claims of efficacy, superiority or regulatory certainty. Programmes under evaluation are not approved for marketing in all listed territories. Medical nutrition and medical food products should be used under the supervision of a healthcare professional.
Interested in a specific asset or stage?
Detailed materials on individual programmes are shared under standard confidentiality terms. Tell us which assets you're interested in and we'll route you to the right team.
Partnership, licensing, regulatory or corporate enquiries — we respond within two working days.
